• 1. Emulsion technologies for multicellular tumour spheroid radiation assays?
  Kay S. McMillan,Anthony G. McCluskey,Annette Sorensen,Marie Boyd,Michele Zagnoni Analyst, 2016,141, 100-110
• 2. Essential effect of the electrolyte on the mechanical and chemical degradation of LiNi0.8Co0.15Al0.05O2 cathodes upon long-term cycling??
  Xiaoming Liu,Zachary D. Hood,Wangda Li,Donovan N. Leonard,Arumugam Manthiram,Miaofang Chi J. Mater. Chem. A, 2021,9, 2111-2119
• 3. Evolution in surface coverage of CH3NH3PbI3?XClXvia heat assisted solvent vapour treatment and their effects on photovoltaic performance of devices
  Dhirendra K. Chaudhary,Pramendra Kumar,Lokendra Kumar RSC Adv., 2016,6, 94731-94738
• 4. Emulsifier-free, organotellurium-mediated living radical emulsion polymerization (emulsion TERP) of styrene: poly(dimethylaminoethyl methacrylate) macro-TERP agent?
  Yukiya Kitayama Polym. Chem., 2014,5, 2784-2792
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Imidazoles Substituted imidazoles

Introduction to 5-Bromo-1,2-dimethyl-1H-imidazole (CAS No. 24134-09-6)

5-Bromo-1,2-dimethyl-1H-imidazole is a heterocyclic organic compound that has garnered significant attention in the field of pharmaceutical and chemical research due to its versatile structural properties and potential applications. With the CAS number 24134-09-6, this compound is recognized for its role as a key intermediate in the synthesis of various biologically active molecules. The presence of both bromine and methyl substituents on the imidazole ring imparts unique reactivity, making it a valuable building block for medicinal chemists and synthetic organic chemists alike.

The imidazole core is a six-membered aromatic ring containing two nitrogen atoms at positions 1 and 3. This structural motif is widely prevalent in nature, particularly in nucleobases such as cytosine and uracil, as well as in numerous pharmacologically relevant compounds. The introduction of bromine at the 5-position and methyl groups at the 1 and 2 positions enhances the compound's utility in cross-coupling reactions, which are fundamental to modern drug discovery and development.

In recent years, 5-Bromo-1,2-dimethyl-1H-imidazole has been explored in the context of developing novel therapeutic agents. Its brominated imidazole structure allows for facile participation in Suzuki-Miyaura, Stille, and Buchwald-Hartwig coupling reactions, enabling the construction of complex molecular architectures. These reactions are pivotal in the synthesis of small-molecule inhibitors targeting various disease pathways, including cancer, inflammation, and infectious diseases.

One of the most compelling applications of 5-Bromo-1,2-dimethyl-1H-imidazole lies in its use as a precursor for kinase inhibitors. Kinases are enzymes that play a critical role in cell signaling cascades, and their dysregulation is implicated in numerous diseases. By leveraging the reactivity of the bromine atom, researchers can introduce this imidazole derivative into libraries of compounds for high-throughput screening (HTS) to identify potent kinase inhibitors. Several studies have demonstrated its efficacy in generating lead compounds that exhibit inhibitory activity against specific kinases, thereby opening avenues for the development of targeted therapies.

The dimethyl-substituted imidazole moiety contributes to the compound's overall stability and lipophilicity, which are desirable properties for drug candidates. These features can influence membrane permeability and binding affinity to biological targets, making 5-Bromo-1,2-dimethyl-1H-imidazole an attractive scaffold for further derivatization. Researchers have employed computational methods to optimize its structure for better pharmacokinetic profiles, ensuring that it meets the stringent criteria for clinical development.

Furthermore, advancements in green chemistry have prompted investigations into sustainable synthetic routes for 5-Bromo-1,2-dimethyl-1H-imidazole. Modern methodologies emphasize minimal waste generation and energy efficiency, aligning with global efforts to reduce the environmental impact of chemical manufacturing. Techniques such as catalytic bromination and microwave-assisted synthesis have been explored to streamline its production while maintaining high yields and purity standards.

The pharmaceutical industry has also recognized the potential of 5-Bromo-1,2-dimethyl-1H-imidazole in addressing unmet medical needs. Its structural flexibility allows medicinal chemists to modulate specific pharmacophoric elements while retaining core biological activity. This adaptability has led to its incorporation into drug candidates targeting neurological disorders, where precise modulation of receptor interactions is essential for therapeutic efficacy.

Recent publications highlight its role in developing antiviral agents. The ability to introduce diverse functional groups into the imidazole ring has enabled researchers to design molecules that interfere with viral replication cycles. By targeting conserved viral enzymes or host factors essential for infection, 5-Bromo-1,2-dimethyl-1H-imidazole derivatives offer promising leads for combating emerging infectious diseases.

The agrochemical sector has not been left behind either. The unique reactivity of this compound has been exploited in creating novel pesticides with improved selectivity and reduced environmental persistence. By integrating 5-Bromo-1,2-dimethyl-1H-imidazole into agrochemical formulations, scientists aim to develop solutions that protect crops without harming beneficial organisms or ecosystems.

In conclusion,5-Bromo-1,2-dimethyl-1H-imidazole (CAS No. 24134-09-6) represents a cornerstone in modern chemical synthesis and drug discovery. Its versatile reactivity and structural features make it indispensable for constructing biologically active molecules across multiple therapeutic areas. As research continues to uncover new applications and sustainable production methods,5-Bromo-1,2-dimethyl-1H-imidazole is poised to remain at the forefront of innovation in pharmaceuticals and beyond.

• 861362-06-3((5-Bromo-1-methyl-1H-imidazol-2-yl)methanol)
• 1003-21-0(5-Bromo-1-methyl-1H-imidazole)
• 502453-54-5(2,2'-Bi-1H-imidazole, 5,5'-dibromo-1,1'-dimethyl-)
• 79326-88-8(5-Bromo-1-methyl-1H-imidazole-2-carbaldehyde)
• 79326-91-3(4-Bromo-1-methyl-1H-imidazole-2-carbaldehyde)
• 850429-59-3(4-Bromo-1,2-dimethyl-1H-imidazole)
• 16954-05-5(4,5-Dibromo-1,2-dimethyl-1H-imidazole)
• 954213-96-8(5-Bromo-2-cyclopropyl-1-methyl-1H-imidazole)
• 1204228-25-0(5-Bromo-1-isopropyl-2-methyl-1h-imidazole)
• 881997-90-6((4,5-Dibromo-1-methyl-1H-imidazol-2-yl)methanol)